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Abstract
The antisickling properties of crude juice extracts of the edible portions of three  commonly 
consumed tropical fruits namely Persia americana, Citrus sinensis, and Carica papaya were 
investigated in vitro alongside  a new drug preparation called Ciklavit® that has antisickling activity. 
Four different solvent extracts of the crude juice of each fruit including aqueous, acidic, alkaline and 
alcoholic extracts were prepared and their antisickling effects on sickle cell trait (HbAS) and sickle cell 
disease (HbSS) blood samples checked alongside Ciklavit®. Blood samples were stabilized using 
normal saline and the antisickling effects were checked by counting the number of sickle cells 
remaining after incubation of the blood samples with the crude fruit extracts and Ciklavit® for twenty-
four hours. The results showed that Ciklavit® produced a sustained reduction in the number of sickle 
cells in both HbAS and HbSS blood samples. Also the alkaline and alcoholic extracts of P. americana 
and C. papaya produced significant reduction in the number of sickle cells. 
Key words: Antisickling, Ciklavit®, Persia americana, Citrus sinensis, Carica papaya
Introduction
Sickle cell disease is encountered in many parts of the world but is predominant in people of 
African, Mediterranean, Indian and Middle Eastern descent as well as blacks and Hispanics in the 
Caribbean and Central America (Bownas, 2000).  The disease is a genetic disorder associated with the 
synthesis of abnormal hemoglobin as a result of point mutation in the gene coding for its beta chain 
resulting in the substitution of glutamic acid with valine (Koch et al., 2000). The affected hemoglobin 
expresses gross changes in its chemical and physical properties especially shape and oxygen-carrying 
capacity. The distorted sickle shape of the Hemoglobin slows down its mobility through blood vessels 
resulting in intensely painful blockage that prevent vital oxygen and nutrients in the blood from 
reaching target organs and tissues thereby impairing their functions (Campbell et al., 1999). This 
results in a number of health problems such as brain damage, thrombosis, liver damage etc. (Enang, 
1992).     
Individuals can either be homozygous for the sickle cell hemoglobin (HbSS) or heterozygous 
(HbAS). The HbAS individuals are termed carriers and do not usually exhibit the grave health 
conditions associated with the HbSS individuals except when they are exposed for a long duration to 
conditions that support sickling (Koch et al., 2000). Certain conditions including low oxygen 
concentration, low pH and high temperature could cause a decrease in solubility of deoxy HbSS, 
leading to its polymerization into fibers that distort its shape and function (sickling). This culminates in
symptoms and complications associated with sickle cell diseases including joint pain, anemia, fever, 
paleness, shortness of breath and jaundice (Bownas, 2000)  
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Treatment of sickle cell disease has proved difficult and inefficient due to its genetic origin. 
Earlier therapies included use of liver-based extracts and diets, oxygen vasodilator, carbonic anhydrase 
inhibitors and spleenectomy. Other conventional therapeutic management involves the use of drugs 
such as piracetam, tucaresol, hydroxyurea as well as bone marrow transplantation and gene therapy (el-
Hazmi et al., 1995; Krishnamurti et al., 2001,Walters, 2005, Bownas, 2000, Dean and Schechter,1978). 
Research is still going on to discover potential antisickling agents, especially from plants (Sofowora et 
al., 1975, Adesina, 2005). The antisickling properties of plants are due to their content of alkaloids, 
resins, phenolics and oils, (Ekong et al., 1975, Elujoba and Nagels, 1985, Sofowora et al., 1975, 
Ouattara et al., 2004). 
Fruits such as Persia americana (Avocado pear); Citrus sinensis (Orange), and Carica papaya (Paw-
paw) are commonly consumed in the tropics and have a wide array of biologically active substances 
which could possibly show antisickling properties comparable to that of a new drug preparation called 
Ciklavit® (Pizzorno and Murray, 1985, Ahmed and Bonner 1980, Daziel, 1955, Bean, 1958,
Cummings and Schroeder, 1942,). Ciklavit® produced from extracts of Cajanus cajan has been shown 
to reverse sickling and clinically reduce the painful crises associated with sickle cell disease (Ogoda et 
al., 2002, Akunsulie et al., 2005).The possible benefits that can accrue from new therapies for sickle 
cell disease from local African fruits in terms of safety and affordability when compared to 
conventional therapies such as hydroxyurea cannot be overemphasized.
Materials and Methods
The edible portion of matured and ripe fruits of Persia americana , Citrus sinensis, and Carica 
papaya bought from a local market were used. Blood samples from consenting and confirmed HbAS 
and HbSS volunteers attending the University of Nigeria Teaching Hospital (UNTH), Enugu, Nigeria 
were used. 
Each (100g) of the washed and peeled fruits was extracted in 100mls of water using a juice 
extractor. The crude paste obtained was then extracted with different solvents. 
Each fruit juice (10mls) was extracted with 5mls of 0.1N HCl by gently shaking the mixture 
for 1 hr in a shaker. The mixture was then centrifuged for 5 mins at 5,000g and the supernatant was 
concentrated to 5mls at 600C in a shaking water bath and retained as the acidic extract.  
Each fruit juice (10mls) was extracted with 5mls of 0.1M NaOH by shaking the mixture 
gently for 1 hr in a shaker. The mixture was then centrifuged for 5 mins at 5, 000g and the supernatant 
concentrated to 5mls at 600C in a shaking water bath and retained as the alkaline extract. 
Each fruit juice (10mls) was extracted with 5mls of 95% ethanol by shaking the mixture and 
they were then centrifuged for 5 mins at 5,000g and the supernatant concentrated to 5mls at 600C in a 
shaking water bath and retained as the alcoholic extract.
Each fruit juice (10mls) was extracted with 5mls of water by shaking gently for 1 hr in a 
shaker. The mixture was centrifuged for 5 mins at 5,000g and the supernatant concentrated to 5mls at 
600C in a shaking water bath and retained as the water extract. 
Antisickling tests 
Antisickling test were done as outlined by Elekwa et al., (2003). Blood samples of HbAA, 
HbAS and HbSS patients were used to check for sickling on grease-free slides. Each blood sample
(0.2mls) and 0.2ml of 2% sodium metabisuphite solution were mixed on slides, covered and rimmed 
with molten wax. The slides were incubated for 24 hrs and viewed under x40 magnification with a 
binocular light microscope (Olympus model CHC-XS2-107BN) for sickling after which sickle cells 
were seen in HbAS and HbSS samples. The antisickling effects were investigated by incubating 0.2mls 
of the acidic, alkaline, alcoholic and water extracts of each of the fruit juice extracts and 0.2mls of 
Ciklavit® solution on covered slides rimmed with molten wax for 24 hrs. The control consisted of only 
HbAS and HbSS blood samples and 2% sodium metabisulphite solution. All the tests were done in 
triplicates. After incubation, the numbers of sickled cells remaining in all the tests were counted under 
a light microscope. 
Statistical analysis
The student t-test was used and statistical significance was checked at 95% confidence 
interval.
Iweala et al., Afr. J. Trad. CAM (2010) 7 (2): 113 - 117 115
Results
Results obtained were expressed as percentage of sickle cells remaining after incubation of 
HbAS and HbSS blood samples with the different fruit extracts and Ciklavit®, as shown in Tables 1- 3. 
Effect of Citrus sinensis on sickling 
The effects of extracts of Citrus sinensis and Ciklavit® on sickling are shown in Table 1.The 
result indicates that Ciklavit® produced remarkable antisickling on HbAS and HbSS blood samples. 
Only the alkaline extract of C. sinensis showed a significant antisickling effect on HbAS blood sample.
Table 1: Antisickling effect of c. sinensis and ciklavit® on hbas and hbss blood 
S/n Test Number of sickle cells (%)
1 HbAS blood alone 52
2 HbAS blood + Ciklavit 10*
3 HbAS blood + water extract 58
4 HbAS blood + Acidic extract 38
5 HbAS blood + Alkaline extract 15*
6 HbAS blood + Alcoholic extract 90
7 HbSS blood alone 92
8 HbSS blood + Ciklavit 25*
9 HbSS blood + water extract 88
10 HbSS blood + alkaline extract 45
11 HbSS blood + Acidic extract 44
12 HbSS blood + alcoholic extract 80
*P≤0.05,n=3
Effect of Carica papaya on sickling
The antisickling effects of Ciklavit® and the extracts of Carica papaya  on HbAS and HbSS 
blood are shown in Table 2. From the results, Ciklavit® produced a significant antisickling effects on 
both blood samples followed by the acidic ,alcoholic and alkaline extracts of C. papaya on HbAS and 
HbSS blood samples respectively.
Table 2: Antisickling effect of c. papaya and ciklavit® on hbas and hbss blood. 
S/n Test Number of sickle cells (%)
1 HbAS blood alone 60
2 HbAS blood + Ciklavit 11*
3 HbAS blood + water extract 54
4 HbAS blood + Acidic extract 60
5 HbAS blood + Alkaline extract 55
6 HbAS blood + Alcoholic extract 15*
7 HbSS blood alone 85
8 HbSS blood + Ciklavit 24*
9 HbSS blood + water extract 53
10 HbSS blood + Acidic extract 58
11 HbSS blood + alkaline extract 28*
12 HbSS blood + alcoholic extract 48
*P≤0.05,n=3
Effect of Persia americana  on sickling.    
The effects of Persia americana and Ciklavit® on sickling in HbSS and HbAS are shown in 
Table 3. Results showed that Ciklavit® produced the highest level of antisickling effect, followed by 
the alkaline and alcoholic extracts of P. americana on HbAS and HbSS blood samples respectively.
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Table 3: Antisickling of p. americana and ciklavit® on hbas and hbss blood. 
S/n Test Number of sickle cells (%)
1 HbAS blood alone 63
2 HbAS blood + ciklavit 11*
3 HbAS blood + water extract 90
4 HbAS blood + Acidic extract 31
5 HbAS blood + Alkaline extract 5*
6 HbAS blood + Alcoholic extract 84
7 HbSS blood alone 91
8 HbSS blood + Ciklavit 24*
9 HbSS blood + water extract 86
10 HbSS blood + Acidic extract 35
11 HbSS blood + alkaline extract 36
12 HbSS blood + alcoholic extract 28*
*P≤0.05,n=3
Discussion
Sickle cell disease is a genetic disease that affects the hemoglobin causing it to assume a 
sickle shape that cannot effectively carry oxygen to tissues and organs. This abnormality results in 
crises and may manifest as symptoms including anemia, pain, fever, jaundice, leg ulcers etc (Koch et 
al., 2000). It has been difficult to find an efficacious cure for this disease because of its genetic origin,
even though it can be managed by using some medications such as hydroxyurea (Bownas, 2000).
Some tropical plants have been found to have antisickling properties and are employed in the 
management of sickle cell disease (Sofowora, 1974, Sofowora et al., 1975, Elekwa et al., 2003. Only 
recently an indigenous pharmaceutical company in Nigeria produced a nutritional preparation called 
Ciklavit® from extracts of Cajanus cajan which purportedly has antisickling properties and is already 
being used in the management of sickle cell disease (Akunsulie et al., 2005). The antisickling potential 
of tropical plants is due to their peculiar content of a wide variety of biologically active substances and 
amino acids capable of reversing sickling (Sofowora, 1975, Ekeke and Shode, 1990) 
The result obtained from this preliminary study confirms the in vitro antisickling property of 
Ciklavit® as well as the potential antisickling activity inherent in some tropical fruits such as Persia 
americana, Citrus sinensis and Carica papaya. These tropical fruits elaborate active constituents 
including essential oils, flavonoids, carotenoids and nitrogenous substances which could express 
antisickling activities in addition to other properties (Iwu, 1985,Thomas and Ajani, 1987, Duke, 1992,
Eskin and Tamir , 2006, Ogunyemi et al., 2008, Elzebrook and Wind, 2008). Further investigations are 
underway to specifically characterize these potential antisickling substances from the fruits.
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